Short-Term Debt to Capital: Adagio Medical Holdings (ADGM)

Adagio Medical Holdings (ADGM) develops innovative cryoablation systems to combat atrial fibrillation, leveraging the approval of iVMT technology and expansion into the US. Adagio Medical Holdings (ADGM) has established a closed technological ecosystem consisting of iBlate catheters and consoles, making it extremely difficult for physicians to switch to alternative solutions. The environmental profile is based on standard plastic and electronics recycling. The metric stands at 0.00. The share price history is presented below.

The development of cryogenic technologies for treating arrhythmias requires immediate funding, meaning the volume of short-term loans relative to equity allows for a real-time assessment of Adagio Medical Holdings (ADGM) liquidity. This metric compares liabilities due within one year to total equity, helping investors distinguish temporary liability restructuring from a systemic crisis, which is critical when analyzing the volatility of the company's share price.